Cargando…
Targeting MEK5 impairs non-homologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
Radiotherapy is commonly used to treat a variety of solid human tumors, including localized prostate cancer. However, treatment failure often ensues due to tumor intrinsic or acquired radioresistance. Here we find that the MEK5/ERK5 signaling pathway is associated with resistance to genotoxic stress...
Autores principales: | Broustas, Constantinos G., Duval, Axel J., Chaudhary, Kunal R., Friedman, Richard A., Virk, Renu K., Lieberman, Howard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085449/ https://www.ncbi.nlm.nih.gov/pubmed/31980741 http://dx.doi.org/10.1038/s41388-020-1163-1 |
Ejemplares similares
-
Modeling Damage Complexity-Dependent Non-Homologous End-Joining Repair Pathway
por: Li, Yongfeng, et al.
Publicado: (2014) -
Involvement of Caveolin-1 in Repair of DNA Damage through Both Homologous Recombination and Non-Homologous End Joining
por: Zhu, Hua, et al.
Publicado: (2010) -
Non-homologous end joining repair in Xenopus egg extract
por: Zhu, Songli, et al.
Publicado: (2016) -
PIAS3 promotes homology-directed repair and distal non-homologous end joining
por: LIU, SHICUI, et al.
Publicado: (2013) -
Nuclear TRADD prevents DNA damage-mediated death by facilitating non-homologous end-joining repair
por: Koo, Gi-Bang, et al.
Publicado: (2017)